🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Tamsulosin formulation-A

Found 10 matching trials

A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia

PHASE1

This study is an open-label, randomized, single dose, multi-stage, cross-ov...

Status

Completed

Location

GSK Investigational Site

Start Date

2011-11-06

Trial ID

NCT01495026

Treatments Being Tested

Dutasteride (0.5mg, fasted state)Dutasteride (0.5mg, fed state)Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fasted state)Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fasted state)Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fasted state)Fixed dose combination capsule containing dutasteride 0.5mg and tamsulosin 0.2mg (fed state)Harnal-D Tablets with water (fasted state)Harnal-D Tablets with water (fed state)Harnal-D tablets without water (fasted state)

A Study to Compare How Tamsulosin is Absorbed to the Body After Administration of Two Types of Tamsulosin Formulation Under Fed and Fasted Conditions in Chinese Healthy Subjects

PHASE1

The purpose of this study is to investigate the relative bioavailability of...

Status

Completed

Location

Multiple Locations

Start Date

2014-04

Trial ID

NCT02138773

Treatments Being Tested

Tamsulosin formulation-A Tamsulosin formulation-B

A Study to Compare the Amount of Drug in the Blood After a Single Tablet EC905 Containing Solifenacin and Tamsulosin is Taken by Healthy Males Compared to Separate Tablets of Solifenacin and Tamsulosin

PHASE1

A study to assess the amount of drug in the blood of young to middle aged, ...

Status

Completed

Location

Parexel

Start Date

2010-03

Trial ID

NCT01953887

Treatments Being Tested

EC905 solifenacin tamsulosin

Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males.

PHASE1

This study aims to determine the relative bioavailability of tamsulosin hyd...

Status

Completed

Location

GSK Investigational Site

Start Date

2011-06-30

Trial ID

NCT01471678

Treatments Being Tested

Dutasteride (0.5mg)FDC product of dutasteride (0.5mg) and tamsulosin HCl (0.2mg)Harnal D Tablets and Harnal Capsules (both comprising 0.2 mg tamsulosin HCl)

Bioequivalence - Duodart Against Avodart & Omnic

PHASE1

Open-label, randomized, single dose, two-treatment, two-way crossover study...

Status

Completed

Location

GSK Investigational Site

Start Date

2012-08-23

Trial ID

NCT01657851

Treatments Being Tested

dutasteride/tamsulosin dutasteride tamsulosin

A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry.

PHASE1

This study will be an open-label, randomized, single dose, two-period cross...

Status

Completed

Location

GSK Investigational Site

Start Date

2010-09-10

Trial ID

NCT01254071

Treatments Being Tested

Dutasteride (0.5mg); Tamsulosin hydrochloride (0.2mg); fixed dose combination product of duatsteride (0.5mg) and tamsulosin hydrochloride (0.2mg)

Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects

PHASE1

The primary objective of this study is to determine the bioavailability of ...

Status

Completed

Location

GSK Investigational Site

Start Date

2015-07-30

Trial ID

NCT02509104

Treatments Being Tested

FDC capsule of dutasteride and tamsulosin Dutasteride soft gelatine capsule and tamsulosin HCl oral disintegrating tablet

A Study to Evaluate the Tolerability and Efficacy of Tamsulosin 0.4mg OCAS Formulation in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2mg Conventional Formulation

PHASE4

This is an open-label, single-arm, prospective interventional study to asse...

Status

Completed

Location

Multiple Locations

Start Date

2013-03

Trial ID

NCT02180789

Treatments Being Tested

Tamsulosin OCAS

A PK Study GL2702 GLARS-NF1 and Omix Ocas® in Healthy Male Volunteers

PHASE1

Study to Investigate The Pharmacokinetics of GL2702 GLARS-NF1 and Omix Ocas...

Status

Completed

Location

Chonbuk National University Hospital

Start Date

2013-08

Trial ID

NCT02072213

Treatments Being Tested

GL2702 GLARS-NF1 Omix Ocas

A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State

PHASE1

This study will be an open-label, randomized, single dose, three way partia...

Status

Completed

Location

GSK Investigational Site

Start Date

2007-10-18

Trial ID

NCT00537654

Treatments Being Tested

Treatment sequence A Treatment sequence B Treatment sequence C Treatment sequence D

Previous Next